This cluster is routine, all sales are cashless exercises of in-the-money options with no material dollar value relative to market cap. No action warranted. Monitor for any upcoming earnings or pipeline news that could trigger more meaningful insider activity.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 29 $570.31entry
- T+1 · 7mo ago +0.13%α −0.89% · $571.06
- T+5 · 7mo ago +4.13%α +1.02% · $593.84
- T+20 · 6mo ago −1.51%α −7.56% · $561.70
- T+60 · 4mo ago −7.15%α −10.89% · $529.53
Price Chart
How similar events traded
Executive Summary
Three insiders at United Therapeutics, including the CEO and CFO, sold a total of $3.48M in open-market shares over a week, with the CEO alone selling $1.17M. The sales are part of routine option exercises and tax withholding transactions, representing only 0.014% of the company's $24.8B market cap, making them immaterial. No unusual insider behavior or catalyst is evident.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt sold 2,067 shares for ~$1.17M across three days (Apr 22-27), all tied to option exercises.
- CFO James Edgemond sold 1,996 shares for ~$1.13M across two days (Apr 23 & 27), all tied to option exercises.
- Director Christopher Patusky sold 2,910 shares for $1.66M on Apr 24, tied to option exercises.
- Total open-market sales: $3.48M, or 0.014% of UTHR's $24.8B market cap.
- All sales were preceded by same-day option exercises at strike prices of $101.80-$146.03, indicating routine cashless exercises.
- No open-market purchases were made by any insider during the cluster window.
Financial Impact
Total insider sales of $3.48M, representing 0.014% of market cap, trivial.
Risk Factors
- No material risk identified from this insider activity.
- If future clusters show a step-change in dollar volume or involve multiple C-suite members selling without option exercises, that would be a red flag.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1777413876758 |
Track record
123 reports on UTHR
4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
- Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers